Scholars Central

Conference abstractPublished 24 Oct 2018

Process development with Chinese Hamster Ovary and hybridoma cell lines: Differences, challenges, things to know

Authors: Robert Swift

Invenux LLC Windsor, US

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

When utilizing different cell lines, expression, productivity and upstream process design, in general, need to be adapted to the metabolism and behavior of these cells. In the upstream process, critical to achieving high biosimilar yields are the choice of the expression system and cell line. For biosimilars, this a rapidly changing landscape as biosimilar manufacturers are no longer bound by technologies used decades ago to produce the original biologic. This Workshop will discuss these choices for Chinese Hamster Ovary (CHO) and Hybridoma cell lines.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “Robert Swift”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels